NL-OMON45496
Completed
Not Applicable
A phase 1, randomized, placebo-controlled study to assess the safety and pharmacokinetics of multiple ascending dose regimens of TP-6076. - TP-6076 MAD study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Infecties.
- Sponsor
- Tetraphase Pharmaceuticals, Inc.
- Enrollment
- 56
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy male or female
- •18\-55 years, inclusive
- •BMI 18\.0\-35\.0 kilogram/meter2
- •Weight between 50 (female) and 60 (male) and 105 kilograms, inclusive
- •Non smokers
Exclusion Criteria
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1\.5 liters of blood in the 10 months prior the start of this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Phase 1, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses Oral Doses of APX001, to Investigate the Effect of Food on APX001 and to Investigate the Drug-Drug Interaction Potential of APX001NL-OMON45345Amplyx Pharmaceuticals, Inc.46
Completed
Phase 1
A trial of BIT225 in patients with HIV-1 infection, to study the safety, concentration and distribution in the body, and anti-viral activity of the drug.ACTRN12612000696897Biotron Limited24
Recruiting
Phase 1
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of PLX-4545 in Healthy VolunteersSolid TumoursCancer - Any cancerACTRN12623001265662Plexium Australia Pty Ltd96
Active, not recruiting
Not Applicable
Study comparing the effect on pain and function of an anaesthetic injection with a placebo (non-active substance) for the treatment of pain at the trapezius muscle.Trapezius muscle pain in patients with fibromyalgiaMedDRA version: 18.0Level: PTClassification code 10048439Term: FibromyalgiaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2015-000796-28-ESFundacio Clinic per a la Recerca Biomèdica
Recruiting
Phase 1
A Study to Evaluate the Safety of a Single and Multiple Oral Doses of a Biologic Therapy (MB-001) or placebo in Healthy Human Participantslcerative colitisUlcerative colitisOral and Gastrointestinal - Inflammatory bowel diseaseACTRN12624000524594Mage Biologics48